BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26750157)

  • 1. The synthetic progesterone Norgestrel is neuroprotective in stressed photoreceptor-like cells and retinal explants, mediating its effects via basic fibroblast growth factor, protein kinase A and glycogen synthase kinase 3β signalling.
    Wyse Jackson AC; Cotter TG
    Eur J Neurosci; 2016 Apr; 43(7):899-911. PubMed ID: 26750157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. bFGF promotes photoreceptor cell survival in vitro by PKA-mediated inactivation of glycogen synthase kinase 3beta and CREB-dependent Bcl-2 up-regulation.
    O'Driscoll C; Wallace D; Cotter TG
    J Neurochem; 2007 Nov; 103(3):860-70. PubMed ID: 17714451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-survival redox signalling in progesterone-mediated retinal neuroprotection.
    Ruiz Lopez AM; Roche SL; Wyse Jackson AC; Moloney JN; Byrne AM; Cotter TG
    Eur J Neurosci; 2017 Jul; 46(1):1663-1672. PubMed ID: 28493650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthetic progestin norgestrel acts to increase LIF levels in the rd10 mouse model of retinitis pigmentosa.
    Byrne AM; Roche SL; Ruiz-Lopez AM; Jackson AC; Cotter TG
    Mol Vis; 2016; 22():264-74. PubMed ID: 27081297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone analogue protects stressed photoreceptors via bFGF-mediated calcium influx.
    Wyse-Jackson AC; Roche SL; Ruiz-Lopez AM; Moloney JN; Byrne AM; Cotter TG
    Eur J Neurosci; 2016 Dec; 44(12):3067-3079. PubMed ID: 27763693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptor signalling in retinal photoreceptor neuroprotection.
    Jackson AC; Roche SL; Byrne AM; Ruiz-Lopez AM; Cotter TG
    J Neurochem; 2016 Jan; 136(1):63-77. PubMed ID: 26447367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing survival of photoreceptor cells in vivo using the synthetic progestin Norgestrel.
    Doonan F; O'Driscoll C; Kenna P; Cotter TG
    J Neurochem; 2011 Sep; 118(5):915-27. PubMed ID: 21689103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling.
    Roche SL; Wyse-Jackson AC; Gómez-Vicente V; Lax P; Ruiz-Lopez AM; Byrne AM; Cuenca N; Cotter TG
    PLoS One; 2016; 11(11):e0165197. PubMed ID: 27814376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic fibroblast growth factor-induced protection from light damage in the mouse retina in vivo.
    O'Driscoll C; O'Connor J; O'Brien CJ; Cotter TG
    J Neurochem; 2008 Apr; 105(2):524-36. PubMed ID: 18088352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractalkine-CX3CR1 signaling is critical for progesterone-mediated neuroprotection in the retina.
    Roche SL; Wyse-Jackson AC; Ruiz-Lopez AM; Byrne AM; Cotter TG
    Sci Rep; 2017 Feb; 7():43067. PubMed ID: 28216676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice.
    Mitton KP; Guzman AE; Deshpande M; Byrd D; DeLooff C; Mkoyan K; Zlojutro P; Wallace A; Metcalf B; Laux K; Sotzen J; Tran T
    Mol Vis; 2014; 20():1527-44. PubMed ID: 25489226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norgestrel, a Progesterone Analogue, Promotes Significant Long-Term Neuroprotection of Cone Photoreceptors in a Mouse Model of Retinal Disease.
    Roche SL; Kutsyr O; Cuenca N; Cotter TG
    Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):3221-3235. PubMed ID: 31335948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial-induced Müller cell gliosis is attenuated by progesterone in a mouse model of retinitis pigmentosa.
    Roche SL; Ruiz-Lopez AM; Moloney JN; Byrne AM; Cotter TG
    Glia; 2018 Feb; 66(2):295-310. PubMed ID: 29034506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia-mediated IGF-I neuroprotection in the rd10 mouse model of retinitis pigmentosa.
    Arroba AI; Alvarez-Lindo N; van Rooijen N; de la Rosa EJ
    Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9124-30. PubMed ID: 22039242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosa.
    Sánchez-Cruz A; Villarejo-Zori B; Marchena M; Zaldivar-Díez J; Palomo V; Gil C; Lizasoain I; de la Villa P; Martínez A; de la Rosa EJ; Hernández-Sánchez C
    Mol Neurodegener; 2018 Apr; 13(1):19. PubMed ID: 29661219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNTF+BDNF treatment and neuroprotective pathways in the rd1 mouse retina.
    Azadi S; Johnson LE; Paquet-Durand F; Perez MT; Zhang Y; Ekström PA; van Veen T
    Brain Res; 2007 Jan; 1129(1):116-29. PubMed ID: 17156753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnosic acid slows photoreceptor degeneration in the Pde6b(rd10) mouse model of retinitis pigmentosa.
    Kang K; Tarchick MJ; Yu X; Beight C; Bu P; Yu M
    Sci Rep; 2016 Mar; 6():22632. PubMed ID: 26961159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The synthetic progestin norgestrel modulates Nrf2 signaling and acts as an antioxidant in a model of retinal degeneration.
    Byrne AM; Ruiz-Lopez AM; Roche SL; Moloney JN; Wyse-Jackson AC; Cotter TG
    Redox Biol; 2016 Dec; 10():128-139. PubMed ID: 27744118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyr61 activates retinal cells and prolongs photoreceptor survival in rd1 mouse model of retinitis pigmentosa.
    Kucharska J; Del Río P; Arango-Gonzalez B; Gorza M; Feuchtinger A; Hauck SM; Ueffing M
    J Neurochem; 2014 Jul; 130(2):227-40. PubMed ID: 24593181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell fate decisions in a human retinal precursor cell line: basic fibroblast growth factor- and transforming growth factor-alpha-mediated differentiation.
    Ezeonu I; Derrickson B; Dutt K
    DNA Cell Biol; 2000 Sep; 19(9):527-37. PubMed ID: 11034546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.